Skip to main content
Clinical Trials/NCT04343898
NCT04343898
Completed
Not Applicable

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Brigham and Women's Hospital1 site in 1 country5,154 target enrollmentApril 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronavirus Infection
Sponsor
Brigham and Women's Hospital
Enrollment
5154
Locations
1
Primary Endpoint
28-Day Mortality
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.

Detailed Description

The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additionally, we will assess outcomes according to differences in geographic and institutional parameters.

Registry
clinicaltrials.gov
Start Date
April 1, 2020
End Date
July 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Leaf

Assistant Professor of Medicine, Harvard Medical School

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

28-Day Mortality

Time Frame: 28-days from the day of ICU admission

Secondary Outcomes

  • 90-Day Mortality(90-days from the day of ICU admission)
  • 60-Day Mortality(60-days from the day of ICU admission)

Study Sites (1)

Loading locations...

Similar Trials